Boardroom Radio - Straight from the source

Australia's Largest Corporate Webcaster

"Boardroom Radio brings companies to my desk. I can hear more investor briefings. Also the calendar is very useful" Matt Williams, Portfolio Manager, Perpetual

"IRESS is always seeking innovative ways to deliver relevant content to our professional user base. Webcasting is a growing and increasingly important way to communicate and we are very pleased to team with Boardroom Radio to further expand our company disclosure information." Peter Dunai, Managing Director, IRESS

"As the investment world continues to become more virtual and the reaction to the release of new investment information becomes faster, Boardroom Radio offers an easy way for all investors to access the latest information for companies." Peter Morgan, Founder 452 Capital

"Boardroom Radio will be a valuable tool to help us manage our time and connect with companies whose stories we wouldn’t normally hear" Ben Griffiths, Eley Griffiths Group

"The service from Boardroom Radio has been outstanding. To hear that we had so many listeners confirmed that Boardroom Radio is an effective communication tool." Roc Oil (ROC)

"Macquarie Airports is happy to trial new and innovative ways of increasing communication to our investors. Boardroom Radio is a particularly easy and flexible method of informing all our stakeholders of MAp's activities." Macquarie Airports (MAP)

"Boardroom Radio provides a modern, highly effective means of communicating Bonaparte's key developments to its shareholders and to a broader spectrum of the investing community in a concise and personal way." Bonaparte Diamond Mines NL

NOVOGEN LIMITED Audio Webcast

Loading presentation... If nothing happens, you may need to install Flash and/or enable javascript in your browser.

Loading audio... If nothing happens please either:

Click to listen to audio on your default player or

Download the latest version of the Flash Player

Prof Alan Husband

Fri, 9 Jan 2009
08:00AM Australia/NSW

Select a tab above to display more information

NOVOGEN LIMITED (NRT)	NRT - Healthy Investment eConference - Christopher Naughton, Managing Director Wed, 1 Jul 2009 12:00PM
BIONOMICS LIMITED (BNO)	BNO - Healthy Investment eConference - Dr Deborah Rathjen, CEO and Managing Director Wed, 1 Jul 2009 11:00AM
BIOPHARMICA LIMITED (BPH)	BPH - Healthy Investment eConference Wed, 1 Jul 2009 10:00AM

NOVOGEN LIMITED (NRT)

ASX code: NRT
Website: http://www.novogen.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
Pharmaceutical research and development and manufacturing and marketing of health supplements.

Address:
, , 140 Wicks Road,
NORTH RYDE
NSW

Phone: (02) 9878 0088
Fax: (02) 9878 0055

Executives & Directors

Mr Philip A Johnston , Chairman, Non Exec. Director
Mr Christopher Naughton , Managing Director, CEO, Executive Director
Mr William D Rueckert , Director
Prof. Alan James Husband , Executive Director
Mr Geoffrey M Leppinus , Non Exec. Director
Prof. Paul J Nestel, AO , Non Exec. Director
Mr Peter B Simpson , Non Exec. Director
Mr David R Seaton , CFO
Mr Ronald L Erratt , Company Secretary

Company Podcasts

Subscribe to current and future audio events for NRT

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

Please refer to the relevant stock exchange if any of the above information is incorrect

NOVOGEN LIMITED (NRT) Events

Company (Stock Code)	Date/Time	Event
NOVOGEN LIMITED (NRT)	Wed, 1 Jul 2009 12:00PM	NRT - Healthy Investment eConference - Christopher Naughton, Managing Director
NOVOGEN LIMITED (NRT)	Mon, 20 Apr 2009 03:30PM	NRT - Novogen’s NV-128 blocks differentiation in cancer stem cells - Professor Alan Husband, Director of Research, Novogen Group
NOVOGEN LIMITED (NRT)	Wed, 15 Apr 2009 12:00PM	NRT - Marshall Edwards to Analyse Ovature Trial - Mr Christopher Naughton, Managing Director
NOVOGEN LIMITED (NRT)	Thu, 9 Apr 2009 01:30PM	NRT - Glycotex Trial Achieves Accelerated Wound Closure - Dr Reinhard Koenig, President and CEO of Glycotex, Inc.
NOVOGEN LIMITED (NRT) Interview with Professor Gil Mor	Fri, 27 Mar 2009 10:30AM	NRT - Novogen`s NV - 128 Targets mTOR Pathway - Professor Alan Husband, Director of Research, Novogen Group
NOVOGEN LIMITED (NRT)	Fri, 27 Feb 2009 11:00AM	NRT - Yale Researchers Present Prostate Results at ASCO - Professor Alan Husband, Director of Research, Novogen Group
NOVOGEN LIMITED (NRT)	Fri, 9 Jan 2009 08:00AM	NRT - Marshall Edwards Granted IND for Triphendiol - Professor Alan Husband, Director of Research, Novogen Group
NOVOGEN LIMITED (NRT)	Wed, 3 Dec 2008 10:15AM	NRT - Healthy Investment eConference - Mr Christopher Naughton, Managing Director
NOVOGEN LIMITED (NRT)	Mon, 3 Nov 2008 12:30PM	NRT - Professor Alan Husband, Director of Research, Novogen Group - 2008 Annual General Meeting
NOVOGEN LIMITED (NRT)	Mon, 3 Nov 2008 12:15PM	NRT - Professor Bryan Williams, MeetingChairman, Marshall Edwards, Inc. - 2008 Annual General
NOVOGEN LIMITED (NRT)	Mon, 3 Nov 2008 12:00PM	NRT - Mr Christopher Naughton, MD - 2008 Annual General Meeting
NOVOGEN LIMITED (NRT)	Mon, 3 Nov 2008 11:45AM	NRT - Mr Philip A Johnston, Chairman - 2008 Annual General Meeting
NOVOGEN LIMITED (NRT)	Thu, 23 Oct 2008 10:15AM	NRT - Glycotex Inc Announces Collaboration - Mr Chris Naughton, MD
NOVOGEN LIMITED (NRT) Capital Raised at Premium to Current Share Price	Fri, 1 Aug 2008 12:00PM	NRT- Raises $5.5m for Marshall Edwards Investment - Mr Chris Naughton, MD
NOVOGEN LIMITED (NRT)	Wed, 2 Apr 2008 01:00PM	NRT - Novogen Cardiovascular Drug Enters Phase I Trial - Mr Chris Naughton, MD
NOVOGEN LIMITED (NRT)	Wed, 5 Dec 2007 01:30PM	NRT - Emerging Companies Online Conference Presentation - Mr Christopher Naughton, MD
NOVOGEN LIMITED (NRT)	Sat, 27 Oct 2007 01:15PM	NRT - 2007 Annual General Meeting - Mr Christopher Naughton, MD
NOVOGEN LIMITED (NRT)	Thu, 30 Aug 2007 05:15PM	NRT - August 2007 Investor Presentation - Mr Christopher Naughton, MD
NOVOGEN LIMITED (NRT)	Tue, 7 Aug 2007 11:30AM	NRT - Subsidiary Raises US$16.4 M and Promising Results for Anti-Inflammatory Drug - Mr Christopher Naughton, MD
NOVOGEN LIMITED (NRT)	Mon, 4 Jun 2007 01:30PM	NRT - Ovarian Tumour Response Trial Recruits First US Patients - Mr Christopher Naughton, MD
NOVOGEN LIMITED (NRT)	Thu, 26 Feb 2009 11:00PM	Interim Results
NOVOGEN LIMITED (NRT)	Fri, 31 Oct 2008 01:30PM	Annual General Meeting AGL Theatre, Museum of Sydney, cnr Phillip and Bridge Streets, Sydney, NSW
NOVOGEN LIMITED (NRT)	Mon, 6 Oct 2008 11:00PM	Full Year Results
NOVOGEN LIMITED (NRT)	Fri, 26 Oct 2007 02:30PM	Annual General Meeting Museum of Sydney, Level 2, Cnr Phillip and Bridge Streets Sydney NSW 2000
NOVOGEN LIMITED (NRT)	Fri, 24 Aug 2007	Full Year Results
NOVOGEN LIMITED (NRT)	Tue, 27 Feb 2007 11:00PM	Interim Results
NOVOGEN LIMITED (NRT)	Sun, 26 Nov 2006 11:00PM	Annual General Meeting
NOVOGEN LIMITED (NRT)	Fri, 25 Aug 2006	Full Year Results
NOVOGEN LIMITED (NRT)	Thu, 23 Feb 2006 11:00PM	Interim Results
NOVOGEN LIMITED (NRT)	Fri, 28 Oct 2005	Annual General Meeting
Displaying 1-20 of 37 events		Display

NOVOGEN LIMITED (NRT)

Click here to view details on the ASX site

IDMC reviews MEIs arrangements for data analysis	Thu, 18 Jun 2009
Response to ASX Query	Tue, 19 May 2009
Novogen`s NV-128 targets mTOR pathway	Mon, 20 Apr 2009
Marshall Edwards to analyse Ovature trial	Wed, 15 Apr 2009
Glycotex on Boardroom Radio	Thu, 9 Apr 2009
Glycotex trial achieves accelerated wound closure	Wed, 8 Apr 2009
Appendix 3B	Wed, 1 Apr 2009
Apendix 3X	Wed, 25 Mar 2009
Board changes at Novogen Limited	Mon, 23 Mar 2009
Triphendiol has acceptable safety profile in animals	Thu, 19 Mar 2009

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.